BioPharma Dive - Latest News

Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot

CEO Keith Gottesdiener will be replaced by Prime's CFO as the company cuts 25% of its workforce and deprioritizes its lead program.

May 19, 2025 - 17:30
 0
Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot

CEO Keith Gottesdiener will be replaced by Prime's CFO as the company cuts 25% of its workforce and deprioritizes its lead program.

Read More

Tags:

Previous Article

Trump asks Supreme Court to permit RIFs at HHS, federal agencies

Next Article

Novavax’s COVID vaccine gets FDA approval, but with limits

Related Posts

Sanofi to pour more than $20B into US drug research and manufacturing

Sanofi to pour more than $20B into US drug research and...

May 15, 2025  0

Regeneron wins bid to buy 23andMe out of bankruptcy

Regeneron wins bid to buy 23andMe out of bankruptcy

May 19, 2025  0

FDA follows EMA in limiting use of Valneva shot

FDA follows EMA in limiting use of Valneva shot

May 12, 2025  0